Oncolytic Virus Therapy Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2015-2020 and Forecast 2021-2027

$ PRICE - $ 3,000.00$ 8,900.00

Oncolytic Virus Therapy Market By Application (Melanoma, Lung Cancer, Breast Cancer, Others), By Type (Monoclonal antibodies, Cancer vaccine, Checkpoint inhibitor and Immunomodulators), By End-Users (Hospitals, Specialty Clinics, Cancer Research Institutes), and Geography

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail

Report

Description

Global Oncolytic Virus Therapy Market was estimated at US$ 103.19 million and is projected to rise CAGR of 25.10% from 2021-2027 to cross US$ 514.36 million by 2027. Oncolytic Virus Therapy Market is one of the most promising and effective virus therapeutics for cancer patients. The virus infects and breaks down the cancer cell in an OV therapy treatment, making it easier for other medicines like chemotherapy to work. Because OV medicines are directly injected into the tumour region, it is also termed as targeted therapy. The market for OV treatment is still in its early stages, with clinical trials underway to see if it can be used to treat a variety of tumours. Melanoma cancer, breast cancer, prostate cancer, and a few other cancer treatments have all been successful. The oncolytic viral therapy market is being driven by the increasing use of target therapy over traditional therapy, the emergence of biosimilars, increased demand for mAbs, and the rising prevalence of cancer. The market is projected to be driven by successful clinical trials and the successful combination of oncolytic viral therapy with chemotherapeutic drugs. Market expansion will be aided by recent technological improvements in cancer treatments and the development of new therapeutics. Oncology encompasses more than 20 different indications, yet only five of them account for the majority of income. Breast cancer, multiple myeloma, non-small-cell lung carcinoma (NSCLC), prostate cancer, and non-lymphoma Hodgkin’s (NHL) will account for around 65% of the market by 2020. These five have high rates of occurrence and unmet needs. Brain, head, and neck cancers, skin cancers, thyroid cancers, pancreas cancers, bladder cancers, kidney and renal pelvis cancers, and soft tissue cancers are all frequent. Breast, lung, colon, and rectum cancers are the three most frequent cancers in women, and they are predicted to account for half of all new cancer diagnoses by 2026. According to the statistics, oncolytic viral therapy has a lot of room to grow in the cancer sector in the near future. In February 2019, Mustang Bio and National Children’s Hospital signed an exclusive worldwide license agreement to produce an oncolytic virus (c134) for treating Glioblastoma Multiforme. In February 2019, Cytonus Therapeutics Inc. revealed that it has created Cargocytes a first-of-its-kind, controllable, cell-based biologic delivery platform technology. In February 2019, Oncolytics Biotech Inc. is currently developing pelareorep, announced that it has been given final approval by the Spanish Department for Medicine and Health Products for the upcoming AWARE-1 breast cancer opportunities research.

 

 


Oncolytic Virus Therapy Market

MARKET SUMMARY
-
25.10%
  • Study Period– 2021-2027
  • Base Year– 2020
  • CAGR– 25.10%
  • Largest Market– North America
  • Fastest Growing Market– Asia-Pacific

Oncolytic Virus Therapy Market

  • The study on global oncolytic virus Therapy Market offers historical, current and future market sizes (US$ Mn) on the basis of application, type, end user, and geography.
  • This study analyses the global market dynamics of oncolytic virus therapy in a detailed manner to identify current trends & drivers, growth opportunities and potential challenges for the main market stakeholders.
  • In addition, the global market report on oncolytic virus therapy covers human demographics, regulatory scenario, and competition analysis with the competition dashboard being vividly demonstrated for assessing market competition.
Market Key Players
  • Amgen
  • Oncolytics Biotech
  • Viralytics
  • Transgene SA
  • Oncolys BioPharma
  • Sorrento Therapeutics
  • Lokon Pharma
  • Vyriad
  • Targovax
  • SillaJen Biotherapeutics
Growth

Oncolytic Virus Therapy Market

In 2015, cancer was responsible for 8.8 million deaths in that year, according to the WHO. Market growth is also powered by technological advances such as natural killer cells and the use of combination therapies. Further production of viral therapies globally, which are in the pipeline, would further accelerate the growth of the market for oncolytic virus therapy. The industry’s difficulties in developing safe and efficient therapies are likely to obstruct market growth over the forecast period. The increasing use of target therapy over conventional therapy, the advent of biosimilars, the demand for mAbs, increased cancer prevalence are factors driving the market for oncolytic virus therapy. In addition, the increasing acceptance of advanced therapeutic options for cancer coupled with rising incidence of cancer, R&D activities in cancer treatments are positively anticipated to boost the global oncolytic virus therapy market. In addition, the difficulties faced in developing safe and effective therapies along with the restricted availability of drugs are the possible restraining factors that hamper the overall growth of the market for oncolytic virus therapy.


North-America Got Significant Share

Oncolytic Virus Therapy Market

Global oncolytic virus therapy market report gives a broad outlook on oncolytic virus therapy with particular emphasis on main regions across the globe such as North America, Europe, Asia Pacific and South America, Middle East and Africa. North America and Europe are expected to account for the largest market share due to the fast acceptance of new potential treatments, high health care R&D spending and the launch of technologically advanced services in the region. The Asia Pacific market is projected to expand at a high CAGR due to the adoption of innovative treatment options that are growing in developing regions, thereby providing the global market with growth opportunities. Countries like India and China is also expected to grow with XX% CAGR due to availability of better care facilities at comparatively lower costs than the Western countries.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Key Findings of the Report

  • The report provides granular level information about the market size, regional market share, historic market (2015 to 2020) and forecast (2021 to 2027)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

Key

Key findings of report:

Oncolytic Virus Therapy Market Segmentation


Location

GEOGRAPHY


Report

Table Of Content

Table of Content

  1. Executive Summary
  2. Global Oncolytic Virus Therapy Market Introduction
    • Global Oncolytic Virus Therapy Market – Taxonomy
    • Global Oncolytic Virus Therapy Market –Definitions
      • By Type
      • By Application
      • By End Use
      • By Region
  1. Global Oncolytic Virus Therapy Market Dynamics
    • Drivers
    • Restraints
    • Opportunities/Unmet Needs of the Market
    • Trends
    • Global Oncolytic Virus Therapy Market Dynamic Factors – Impact Analysis
    • Global Oncolytic Virus Therapy Market – Competition Landscape
  2. Global Oncolytic Virus Therapy Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026
    • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
    • Year-over-Year (Y-o-Y) Growth Analysis (%)
    • Market Opportunity Analysis
  3. Global Oncolytic Virus Therapy Market, By Type, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
    • Monoclonal antibodies
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Cancer vaccines
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

Global Oncolytic Virus Therapy Market 2015-2019 and Forecast 2020-2026

  • Market Opportunity Analysis
  • Checkpoint inhibitors
    • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
    • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
    • Market Opportunity Analysis
  1. Global Oncolytic Virus Therapy Market Forecast, By Application, 2015 – 2019 and Forecast, 2019 – 2025 (Revenue, USD Mn)
    • Melanoma
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Lung Cancer
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Breast Cancer
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Others
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Oncolytic Virus Therapy Market Forecast, By End Use, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
    • Hospitals
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

Global Oncolytic Virus Therapy Market 2015-2019 and Forecast 2020-2026

  • Market Opportunity Analysis
  • Specialty Clinics
    • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
    • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
    • Market Opportunity Analysis
  • Cancer Research Institutes
    • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
    • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
    • Market Opportunity Analysis
  1. Global Oncolytic Virus Therapy Market Forecast, By Region, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
    • North America
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Europe
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Asia-Pacific
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Latin America
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Middle East and Africa
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)

Global Oncolytic Virus Therapy Market 2015-2019 and Forecast 2020-2026

  • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  • Market Opportunity Analysis
  • Global Oncolytic Virus Therapy Market – Opportunity Analysis Index, By Type, By Application, By End Use, and Region, 2020 – 2026
  1. North America Oncolytic Virus Therapy Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
    • Type Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Monoclonal antibodies
      • Cancer vaccines
      • Checkpoint Inhibitors
    • Application Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Melanoma
      • Lung Cancer
      • Breast Cancer
      • Others
    • End Use Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospitals
      • Specialty Clinics
      • Cancer Research Institutes
    • Country Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • USA
      • Canada
    • North America Oncolytic Virus Therapy Market – Opportunity Analysis Index, By Type, By Application, By End Use, and Country, 2020 – 2026
    • North America Oncolytic Virus Therapy Market Dynamics – Trends

Global Oncolytic Virus Therapy Market 2015-2019 and Forecast 2020-2026

  1. Europe Oncolytic Virus Therapy Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
    • Type Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Monoclonal antibodies
      • Cancer vaccines
      • Checkpoint Inhibitors
    • Application Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Melanoma
      • Lung Cancer
      • Breast Cancer
      • Others
    • End Use Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospitals
      • Specialty Clinics
      • Cancer Research Institutes
    • Country Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Germany
      • UK
      • France
      • Spain
      • Italy
      • Rest of Europe
    • Europe Oncolytic Virus Therapy Market – Opportunity Analysis Index, By Type, By Application, By End Use, and Country, 2020 – 2026
    • Europe Oncolytic Virus Therapy Market Dynamics – Trends

Global Oncolytic Virus Therapy Market 2015-2019 and Forecast 2020-2026

  1. Asia-Pacific Oncolytic Virus Therapy Market Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
    • Type Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Monoclonal antibodies
      • Cancer vaccines
      • Checkpoint Inhibitors
    • Application Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Melanoma
      • Lung Cancer
      • Breast Cancer
      • Others
    • End Use Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospitals
      • Specialty Clinics
      • Cancer Research Institutes
    • Country Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Japan
      • China
      • India
      • Australia & New Zealand
      • Rest of APAC
    • Asia-Pacific Oncolytic Virus Therapy Market – Opportunity Analysis Index, By Type, By Application, By End Use, and Country, 2020 – 2026
    • Asia-Pacific Oncolytic Virus Therapy Market Dynamics – Trends

Global Oncolytic Virus Therapy Market 2015-2019 and Forecast 2020-2026

  1. Latin America Oncolytic Virus Therapy Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
    • Type Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Monoclonal antibodies
      • Cancer vaccines
      • Checkpoint Inhibitors
    • Application Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Melanoma
      • Lung Cancer
      • Breast Cancer
      • Others
    • End Use Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospitals
      • Specialty Clinics
      • Cancer Research Institutes
    • Country Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
    • Latin America Oncolytic Virus Therapy Market – Opportunity Analysis Index, By Type, By Application, By End Use, and Country, 2020 – 2026
    • Latin America Oncolytic Virus Therapy Market Dynamics – Trends
  2. Middle East and Africa Oncolytic Virus Therapy Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)

Global Oncolytic Virus Therapy Market 2015-2019 and Forecast 2020-2026

  • Type Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
    • Monoclonal antibodies
    • Cancer vaccines
    • Checkpoint Inhibitors
  • Application Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    • Melanoma
    • Lung Cancer
    • Breast Cancer
    • Others
  • End Use Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    • Hospitals
    • Specialty Clinics
    • Cancer Research Institutes
  • Country Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
    • GCC Countries
    • Israel
    • South Africa
    • Turkey
    • Rest of MEA
  • MEA Oncolytic Virus Therapy Market – Opportunity Analysis Index, By Type, By Application, By End Use, and Country, 2020 – 2026
  • MEA Oncolytic Virus Therapy Market Dynamics – Trends
  1. Competition Landscape
    • Strategic Dashboard of Top Market Players

Global Oncolytic Virus Therapy Market 2015-2019 and Forecast 2020-2026

  • Company Profiles (Introduction, Financial Analysis, Application & Application Offerings, Key Developments, Strategies, and SWOT Analysis)
    • Amgen
    • Oncolytics Biotech
    • Viralytics
    • Transgene SA
    • Oncolys BioPharma
    • Sorrento Therapeutics
    • Lokon Pharma
    • Vyriad
    • Targovax
    • SillaJen Biotherapeutics
  1. Research Methodology
  2. Key Assumptions and Acronyms

Report

Company Profile

  • Amgen
  • Oncolytics Biotech
  • Viralytics
  • Transgene SA
  • Oncolys BioPharma
  • Sorrento Therapeutics
  • Lokon Pharma
  • Vyriad
  • Targovax
  • SillaJen Biotherapeutics

Description

Global Oncolytic Virus Therapy Market was estimated at US$ 103.19 million and is projected to rise CAGR of 25.10% from 2021-2027 to cross US$ 514.36 million by 2027. Oncolytic Virus Therapy Market is one of the most promising and effective virus therapeutics for cancer patients. The virus infects and breaks down the cancer cell in an OV therapy treatment, making it easier for other medicines like chemotherapy to work. Because OV medicines are directly injected into the tumour region, it is also termed as targeted therapy. The market for OV treatment is still in its early stages, with clinical trials underway to see if it can be used to treat a variety of tumours. Melanoma cancer, breast cancer, prostate cancer, and a few other cancer treatments have all been successful. The oncolytic viral therapy market is being driven by the increasing use of target therapy over traditional therapy, the emergence of biosimilars, increased demand for mAbs, and the rising prevalence of cancer. The market is projected to be driven by successful clinical trials and the successful combination of oncolytic viral therapy with chemotherapeutic drugs. Market expansion will be aided by recent technological improvements in cancer treatments and the development of new therapeutics. Oncology encompasses more than 20 different indications, yet only five of them account for the majority of income. Breast cancer, multiple myeloma, non-small-cell lung carcinoma (NSCLC), prostate cancer, and non-lymphoma Hodgkin’s (NHL) will account for around 65% of the market by 2020. These five have high rates of occurrence and unmet needs. Brain, head, and neck cancers, skin cancers, thyroid cancers, pancreas cancers, bladder cancers, kidney and renal pelvis cancers, and soft tissue cancers are all frequent. Breast, lung, colon, and rectum cancers are the three most frequent cancers in women, and they are predicted to account for half of all new cancer diagnoses by 2026. According to the statistics, oncolytic viral therapy has a lot of room to grow in the cancer sector in the near future. In February 2019, Mustang Bio and National Children’s Hospital signed an exclusive worldwide license agreement to produce an oncolytic virus (c134) for treating Glioblastoma Multiforme. In February 2019, Cytonus Therapeutics Inc. revealed that it has created Cargocytes a first-of-its-kind, controllable, cell-based biologic delivery platform technology. In February 2019, Oncolytics Biotech Inc. is currently developing pelareorep, announced that it has been given final approval by the Spanish Department for Medicine and Health Products for the upcoming AWARE-1 breast cancer opportunities research.

 

 

ASIA PACIFIC OFFICE

Precision Business Insights, 5th Floor, Mohan’s Elite, Opp : Bharat Petroleum Pump, Khanamet Road, Hitech City, Hyderabad – 500084

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX